Abstract:Abstract Lung cancer is the most common cancer, which also leading cause of global cancer mortality. Metastasis is a complex multi-step process that represents the most deadly aspect of cancer. One key step in metastasis is the entry of circulating tumor cells (CTCs) into secondary or distant organ sites to become disseminated tumor cells for subsequent metastasis. Exosomes, a subset of extracellular vesicles (EVs), function as a mode of intercellular communication and molecular transfer. Tumor cells are avid producers of exosomes, and tumour-derived exosomes uptaken by organ-specific cells prepare the pre-metastatic niche. The aim of this pilot study is to investigate the relationship between the count of circulating tumor cells in peripheral blood and the clinical stage of lung cancer, and the difference between normal (healthy) person exosomes and cancer patients exosomes in the rate of exosomes release and the content (most notably proteins). A total of 140 patients participated in the project and twelve blood samples from healthy volunteers were also collected in the Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. After obtaining the informed consent, blood samples (5 ml) were stored in the ACD anticoagulant tube. CTCs was counted by immunomagnetic beads negative enrichment technique combined with immunofluorescence staining of chromosome in situ hybridization. The correlation between the count of CTCs and the clinical stage was analyzed. Exosomes were isolated by Density Gradient (DG) centrifugation. Exosomes concentration and size was analyzed by Nanoparticle Tracking Analysis (NTA), and protein was analyzed by HPLC-CHIP-MS/MS. In 114 patients, the positive rate of CTCs was 93.86% (in 3.2mL blood CTCs≥1, 107/114). The count of CTCs was negatively correlated with clinical stage (rs=-0.279, p=0.003), which suggest that CTCs is highly expressed in early lung cancer patients. Exosomes test results showed that there was a significant difference between lung cancer patients and healthy person. The size of exosome in healthy person was significantly smaller and the concentration was significantly higher when compared with lung cancer patients (p<0.05). In addition, the mass spectrometry results showed that the control group had 135 proteins in the exosomes, while the patient group contained 167 proteins, which 89 proteins were shared with each other. These results suggest that CTCs plays an important role in the pathogenesis of lung cancer and should be a target for early postoperative metastasis. The analysis of exosomes in NSCLC could represent a noninvasive test for assess disease progression. Citation Format: Zujun Que, Yi Jiang, Fangfang Qian, Zhi Qiao, Hua Xiao, Lingshuang Liu, Hegen Li, Jianhui Tian. Correlation of exosomes and CTCs in non-small cell lung cancer patients with disease stage [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 1577.

Expression Profiles and Clinical Value of Plasma Exosomal Tim-3 and Galectin-9 in Non-Small Cell Lung Cancer.

PLA2G10 Incorporated in Exosomes Could Be Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer

Proteomic Analysis of Plasma Exosomes in Patients with Non-Small Cell Lung Cancer

Plasma exosome-derived B-cell translation gene 1: a predictive marker for the prognosis in patients with non-small cell lung cancer

Identification of Exosome Protein Panels As Predictive Biomarkers for Non-Small Cell Lung Cancer

Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.

T Cell Immunoglobulin and Mucin-Domain Containing-3 in Non-Small Cell Lung Cancer

Correlation of Plasma Exosomal Micrornas with the Efficacy of Immunotherapy Inegfr/alkwild-Type Advanced Non-Small Cell Lung Cancer

Plasma Exosomal Trna‐derived Fragments As Diagnostic Biomarkers in Non-Small Cell Lung Cancer

Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer

Application Value of Plasma Exosomal Long RNA in SCLC Diagnosis and Prognosis.

Glypican-1 in Serum-Derived Exosomes As a Potential Biomarker in Liquid Biopsy of Non-Small Cell Lung Cancer

Plasma exosomes contain protein biomarkers valuable for the diagnosis of lung cancer

Plasma Extracellular Vesicle Long RNA in Diagnosis and Prediction in Small Cell Lung Cancer.

Extracellular RNA profiles in non-small cell lung cancer plasma

Plasma RNA sequencing of extracellular RNAs reveals potential biomarkers for non-small cell lung cancer

Integrin β5 in plasma-derived exosomal protein predicting liver-specific metastasis in advanced gastric cancer patients.

Exosomal TMEM88 Protein As a Potential Biomarker in Liquid Biopsy for Non-Small-cell Lung Cancer

Comprehensive analysis of exosome gene LYPD3 and prognosis/immune cell infiltration in lung cancer

P1.12-19 Identification and Potential Application of Human Blood Exosomal RNA in Small Cell Lung Cancer

Abstract 1577: Correlation of Exosomes and CTCs in Non-Small Cell Lung Cancer Patients with Disease Stage